Senseonics Holdings, Inc. (SENS) Insider Trading Activity

NASDAQ$9.09+0.23 (2.60%)
Market Cap
$468.46M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
152 of 849
Rank in Industry
22 of 107

SENS Insider Trading Activity

SENS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$737,255
8
100
Sells
$0
0
0

Related Transactions

ROEDER DOUGLAS Adirector
4
$439,160
0
$0
$439,160
Goodnow Timothy TPresident and CEO
2
$200,755
0
$0
$200,755
Steven Edelmandirector
1
$65,500
0
$0
$65,500
Sullivan Frederick T.Chief Financial Officer
1
$31,840
0
$0
$31,840

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an …

Insider Activity of Senseonics Holdings, Inc.

Over the last 12 months, insiders at Senseonics Holdings, Inc. have bought $737,255 and sold $0 worth of Senseonics Holdings, Inc. stock.

On average, over the past 5 years, insiders at Senseonics Holdings, Inc. have bought $401,627 and sold $2.26M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ROEDER DOUGLAS A (director) — $439,160. Goodnow Timothy T (President and CEO) — $200,755. Steven Edelman (director) — $65,500.

The last purchase of 13,953 shares for transaction amount of $125,300 was made by ROEDER DOUGLAS A (director) on 2026‑08‑19.

List of Insider Buy and Sell Transactions, Senseonics Holdings, Inc.

2026-08-19PurchaseROEDER DOUGLAS Adirector
13,953.28
0.0329%
$8.98
$125,300
+2.41%
2026-05-12PurchaseROEDER DOUGLAS Adirector
22,686
0.0524%
$5.56
$126,134
+28.99%
2026-03-13PurchaseGoodnow Timothy TPresident and CEO
17,225
0.0423%
$5.79
$99,733
+20.21%
2026-03-13PurchaseROEDER DOUGLAS Adirector
17,500
0.0426%
$5.73
$100,275
+20.21%
2025-11-10PurchaseSteven Edelmandirector
10,000
0.0267%
$6.55
$65,500
+7.27%
2025-11-07PurchaseGoodnow Timothy TPresident and CEO
17,210
0.0352%
$5.87
$101,023
+12.98%
2025-11-07PurchaseSullivan Frederick T.Chief Financial Officer
5,415
0.0111%
$5.88
$31,840
+12.98%
2025-11-07PurchaseROEDER DOUGLAS Adirector
15,000
0.0305%
$5.83
$87,450
+12.98%
2024-12-13PurchaseROEDER DOUGLAS Adirector
75,000
0.0137%
$0.50
$37,500
+12.86%
2024-12-12PurchaseSullivan Frederick T.Chief Financial Officer
124,933
0.0182%
$0.38
$47,475
+16.82%
2024-12-12PurchaseROEDER DOUGLAS Adirector
300,000
0.0471%
$0.41
$123,000
+16.82%
2024-12-10PurchaseGoodnow Timothy TPresident and CEO
315,000
0.0531%
$0.31
$97,650
+63.74%
2023-09-07SaleLarkin Sharondirector
30,889
0.0062%
$0.61
$18,842
-14.29%
2023-08-30PurchaseROEDER DOUGLAS Adirector
300,000
0.0619%
$0.54
$162,000
-1.79%
2022-08-04SaleJAIN MukulChief Operating Officer
50,000
0.0103%
$1.97
$98,500
-47.78%
2022-03-11SaleFiorentino Edward
63,553
0.014%
$1.65
$104,862
-28.35%
2022-02-11SaleGoodnow Timothy TPresident and CEO
464,390
0.1035%
$2.46
$1.14M
-50.41%
2022-02-11SaleJAIN MukulChief Operating Officer
150,197
0.0335%
$2.46
$369,485
-50.41%
2022-02-11SaleKaufman FrancineChief Medical Officer
163,870
0.0365%
$2.46
$403,120
-50.41%
2022-02-11SaleHorton Kenneth LGC & Corp. Development Advisor
143,126
0.0319%
$2.46
$352,090
-50.41%
Total: 93
*Gray background shows transactions not older than one year

Insider Historical Profitability

30.01%
Goodnow Timothy TPresident and CEO
651243
1.2317%
$5.77M44
+19.26%
ROEDER DOUGLAS Adirector
171191
0.3238%
$1.52M811
+9.85%
Sullivan Frederick T.Chief Financial Officer
157028
0.297%
$1.39M20
+16.82%
Steven Edelmandirector
74708
0.1413%
$661,912.8811
BARRETT M JAMES
21911183
41.4403%
$194.13M20
+55.39%
NEW ENTERPRISE ASSOCIATES 10 L P10 percent owner
19476414
36.8355%
$172.56M223
+55.39%
Delphi Management Partners VIII, L.L.C.10 percent owner
11237221
21.2528%
$99.56M10
+11.5%
NEW ENTERPRISE ASSOCIATES 9 L P10 percent owner
8949292
16.9257%
$79.29M10
+11.5%
BARRIS PETER J10 percent owner
0
0%
$023
+55.39%
*Gray background shows insiders who have made transactions during last year

SENS Institutional Investors: Active Positions

Increased Positions55+26.32%2M+13.58%
Decreased Positions98-46.89%10M-68.52%
New Positions38New1MNew
Sold Out Positions74Sold Out2MSold Out
Total Postitions166-20.57%7M-54.94%

SENS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Hood River Capital Management Llc$50,384.0020.86%8.55M+8M+2,059.26%2025-09-30
Vanguard Group Inc$10,078.004.17%1.71M+37,472+2.24%2025-09-30
First Light Asset Management, Llc$5,303.002.2%900,382-885,024-49.57%2025-09-30
Blackrock, Inc.$4,598.001.9%780,693-5,940-0.76%2025-09-30
Geode Capital Management, Llc$2,645.001.1%448,983+13,927+3.2%2025-09-30
Masters Capital Management Llc$1,473.000.61%250,000+25,000+11.11%2025-09-30
Charles Schwab Investment Management Inc$1,295.000.54%219,863+4,475+2.08%2025-09-30
State Street Corp$1,293.000.54%219,484+8,726+4.14%2025-09-30
Ubs Group Ag$1,251.000.52%212,426+170,693+409.01%2025-09-30
Beck Mack & Oliver Llc$1,042.000.43%176,950+168,102+1,899.89%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.